Translating local innovation into statewide policy: Lessons from a medications for addiction treatment (MAT) prior authorization pilot in Camden, New Jersey

Author
Natasha Dravid and Alex Staropoli
Date
August 19, 2019
January 14, 2021
Camden Coalition pilots DEI discussion series
The Camden Coalition pilots a series of internal diversity, equity, and inclusion (DEI) conversations to discuss race, equity, and health justice.
Lisa Mojica and Danielle Hodges, Chair and Vice-Chair Camden Coalition DEI Committee
December 22, 2020
Op-ed: Our Medical Director shares why he is eager to receive the COVID-19 vaccine
The Camden Coalition's Medical Director, Dr. Jubril Oyeyemi, provides assurance about the safety and efficacy of the new COVID-19 vaccine.
Jubril Oyeyemi
Medical provider holds a cellphone in hands
October 2, 2020
Two new data sources for the Camden Coalition HIE broaden its impact and scope
New long-term care and hospital admission, discharge, and transfer data make the Camden Coalition HIE even more useful for providers in South Jersey.
Christine McBride and Natasha Dravid
Stock photo of brown paper grocery bags filled with fresh produce and bagels
September 8, 2020
Tackling the “last mile” of safety-net food access during the COVID-19 pandemic
Collaborations in Camden leverage an NEMT provider's infrastructure to address food insecurity during the COVID-19 pandemic.
Evelyne Kane, Jamie Moses, Joe Hejlek, and Benjamin Ovadia
August 13, 2020
Responding to COVID-19 by expanding the Camden Coalition’s HIE functionalities
New additions to the Camden Coalition HIE give South Jersey more insight into COVID-19 in the region.
Christine McBride, Audrey Hendricks, and Natasha Dravid
June 2, 2020
Note from our CEO on what is happening in our communities
Join us in not only denouncing racism and institutional violence, but in taking action to ensure equity as well.
Kathleen Noonan

Between 2016 and 2017, New Jersey had the second highest increase in overdose deaths in the country. Improving access to medications for addiction treatment (MAT) is a critical tool in preventing these avoidable deaths. Having identified prior authorization as a barrier to accessing buprenorphine — one form of MAT — the Camden Coalition worked with local stakeholders to implement a pilot program that eliminated prior authorization for this life-saving medication in certain circumstances. The successful results of the pilot, along with collective advocacy at the state level, led to the removal of this administrative barrier for Medicaid beneficiaries across the state of New Jersey earlier this year. 

This Camden Coalition brief outlines the nuts and bolts of the pilot program and our work alongside partners at the local and state levels to translate the pilot into successful statewide policy.

Read the brief

Stay Informed

Join our mailing list to get the latest updates sent right to your inbox from the Camden Coalition.

Sign Up